MAPK8 and metabolic dysfunction-associated steatohepatitis: ZDHHC3 further exhibited promoted effects on NASH progression by activating IRHOM2 and its downstream MAP3K7‐JNK cascade signaling, thereby increasing hepatosteatosis, inflammation, and collagen accumulation.